Bladder Cancer,Genitourinary Cancer Erdafitinib in BCG-Resistant HR NMIBC With FGFR Mutations Dec 20, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Pembro vs. Pbo in High-Risk Early ER+/HER2- Breast Cancer Dec 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Lorlatinib Efficacy Against Advanced LC With ALK Gene Mutation Dec 19, 2023
